Nantahala Capital Management, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT)

Filing Manager
Nantahala Capital Management, LLC
Reporting Manager
Nantahala Capital Management, LLC
Security
RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share
Symbol
RAPT
Shares outstanding
16,532,679 shares
Disclosed Ownership
623,282 shares
Ownership
3.8%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:32:43 UTC
Date of event
30 Sep 2025
Previous filing
14 Aug 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Nantahala Capital Management, LLC disclosed 3.8% ownership in RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT) on 30 Sep 2025."

Quick Takeaways

  • Nantahala Capital Management, LLC filed SCHEDULE 13G/A for RAPT Therapeutics, Inc. Common Stock $0.0001 par value per share (RAPT).
  • Disclosed ownership: 3.8%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 14 Aug 2025.
  • Current filing was accepted on 14 Nov 2025, 16:32.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nantahala Capital Management, LLC 3.8% 623,282 0 623,282 /s/ Taki Vasilakis Taki Vasilakis / Chief Compliance Officer
Wilmot B. Harkey 3.8% 623,282 0 623,282 /s/ Wilmot B. Harkey Wilmot B. Harkey
Daniel Mack 3.8% 623,282 0 623,282 /s/ Daniel Mack Daniel Mack

Sponsored